Yalcin, I. Et Al. 2018. Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.23, no.2 , 329-337.

Yalcin, I., Meydanli, M. M., Turan, A. T., TAŞKIN, S., Sari, M. E., Gungor, T., ... Akbayir, O.(2018). Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.23, no.2, 329-337.

Yalcin, Ibrahim Et Al. "Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment," INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.23, no.2, 329-337, 2018

Yalcin, Ibrahim Et Al. "Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.23, no.2, pp.329-337, 2018

Yalcin, I. Et Al. (2018) . "Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment." INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.23, no.2, pp.329-337.

@article{article, author={Ibrahim Yalcin Et Al. }, title={Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment}, journal={INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY}, year=2018, pages={329-337} }